Home › Funds › CFG Wealth Management Services, Inc. › ALLO

CFG Wealth Management Services, Inc. position in ALLO

ALLOGENE THERAPEUTICS INC · Health Care

CFG Wealth Management Services, Inc. reported holding 40,000 shares of ALLO (ALLOGENE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$122K, representing 0.12% of its reported portfolio and ranking #36 among its reported holdings. CFG Wealth Management Services, Inc. has disclosed ALLO holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)40.00K sh
Reported value held$122.00K
Portfolio Weight0.12%
First reportedQ1 2026
Last changeNew

How CFG Wealth Management Services, Inc.'s ALLO position evolved

CFG Wealth Management Services, Inc. first disclosed a stake in ALLO in Q1 2026 at 40,000 shares (US$122K). Across 2 filings, CFG Wealth Management Services, Inc. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 40,000 shares valued at US$122K.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 40.00K $122.00K New
Q2 2026 40.00K $122.00K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ALLO and 13F data

ALLO (ALLOGENE THERAPEUTICS INC) is a Health Care company. 45 other funds we track also report a position in ALLO — the largest reported positions include PFIZER INC (US$46.9M), Frazier Life Sciences Management, L.P. (US$46.7M), TPG GP A, LLC (US$38.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ALLO

All ALLO fund holders →